Sökt på: Sökresultat
totalt 13 träffar
DNA Topoisomearases: Biochemistry and Molecular Biology
Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular basis of drug action, both applied and …
Gutachten Zum Internationalen Und Ausl?ndischen Privatrecht, 1969
Cyclic GMP: Synthesis, Metabolism, and Function
This volume is dedicated to the topic of cyclic GMP. Chapters include discussions on the guanylyl cyclase and phosphodiesterase isoenzyme families for cyclic GMP synthesis and …
Deutsche Landesreferate Zum V. Internationalen Kongre? F?r Rechtsvergleichung in Br?ssel 1958
Advances in Pharmacology
Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and …
Conjugation-Dependent Carcinogenicity and Toxicity of Foreign Compounds
Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular basis of drug action, both applied and …
Gutachten Zum Internationalen Und Ausl?ndischen Privatrecht
HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms
This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new …
HIV I: Molecular Biology and Pathogenesis: Clinical Applications
The cumulative death toll from AIDS has reached 16.3 million individuals, and more than 33 million persons are currently living with HIV-1. Although it is one of the most-widely …
Gutachten Zum Internationalen Und Ausl?ndischen Privatrecht
Drug-Drug Interactions: Scientific and Regulatory Perspectives
Drug?Drug Interactions is a comprehensive review of the scientific and regulatory perspectives of drug?drug interactions from the point-of-view of academia, industry, and …
Collaborative Innovation in Drug Discovery
Can academia save the pharmaceutical industry? The pharmaceutical industry is at a crossroads. The urgent need for novel therapies cannot stem the skyrocketing costs and …